Pre-hospital Thrombolysis for ST-segment Elevation Myocardial Infarction in Regional Australia: Long Term Follow Up.
Delivering reperfusion therapy to patients with ST-segment elevation myocardial infarction (STEMI) in regional areas without access to tertiary cardiology care remains challenging. The systems of care in Hunter New England Health, NSW Australia (Area covered = 130, 000 square kilometres) to provide reperfusion to patients with STEMI involve a 12-lead electrocardiogram in the ambulance, discussion between cardiologist and paramedic, followed by prehospital thrombolysis (PHT) delivered in ambulance to appropriate patients > 60 minutes from the CCL. Patients who can access the CCL within 60 minutes are treated with primary percutaneous coronary intervention (PCI). We have previously reported excellent 12-month outcomes for patients receiving PHT. Whether these outcomes are sustained in the longer term remains unknown. We assessed long term all-cause mortality and major adverse cardiovascular events of STEMI patients undergoing PHT in our health district from August 2008 to August 2013 and compared with the primary PCI group. One hundred and fifty patients (mean age: 62±13 years, Males: 76%, n=114) were administered PHT and 334 patients (mean age: 65±13 years, Males: 75 %, n=251) underwent primary PCI during the study period. During a median follow up of 6.2 years (IQR: 4.8 - 7.4 years) all-cause mortality was 16% and 19% in the PHT and primary PCI groups respectively (P: 0.4). Our real-world experience shows that PHT followed by early transfer to a primary PCI-capable centre is an effective reperfusion strategy, with comparable results to primary PCI, and mortality benefits are sustained to more than 6 years. This article is protected by copyright. All rights reserved.